Director Roy Doumani sold $1.4M of Kite Pharma, Inc.

Sold$1,399,815

$74.46Price

18,800Shares

−16%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Wed, Mar 1. Filed Thu, Mar 2, 1:06 AM ET, before the open. Not investment advice.